Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3193348 | Annals of Allergy, Asthma & Immunology | 2007 | 4 Pages |
Abstract
Etoricoxib, like other cyclooxygenase-2 inhibitors, is a well-tolerated drug in most NSAID-sensitive patients. However, according to our experience, a previous challenge test in a safe environment may be necessary before prescribing the drug to such patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Lionello MD, Mariateresa MD, Gianfranco MD, Fabio MD, Eugenio MD, Maurizio MD, Antonio MD,